Baby Comfy Care won this year’s Drug Store News/ECRM Best Product Award in the personal care, oral and baby category for its Deluxe Safety Nail Clipper at ECRM’s Personal Care, Oral and Baby event from July 12 to 15. St. Louis-based Handi-Craft Co. was named as the finalist for the Dr. Brown’s Options Baby Bottle.
Menasha has announced that, during the Point of Purchase Advertising International’s 2nd Annual East Coast POP-UP Creative Gallery held in late May, it won a POP-UP Creative Award for its Coty Sally Hansen Miracle Gel family display.
Nail care company Red Carpet Manicure has announced the launch of the limited edition Cinderella Collection in partnership with Walt Disney for the release of the live-action version of “Cinderella” hitting theaters on March 13.
Safe 'N' Beautiful, the Greek cosmetics brand behind Snails nail polish for children and S'N'B Wash Off polishes for women, has experienced rapid growth with a 496% increase in global sales and is set to further expand the Snails and S'N'B brands to additional countries, the company announced.
Beauty company Coty Inc. had a “challenging year” in fiscal 2014 as net revenues declined because of pressure on its nail business and fierce competition from rivals. However, the company is starting to see the first sign of a turnaround in its nail business thanks to the new Sally Hansen Miracle Gel.
CCA Industries, whose brands include Plus+White toothpastes and teeth whiteners, Nutra Nail nail care treatments and Scar Zone scar treatment, widened its net loss during second quarter 2014, and has pulled the plug on its Gel Perfect brand.
Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.
DSN recently talked Coty’s chief scientific officer Ralph Macchio about the company's new, state-of-the-art research and development facility in Morris Plains, N.J., for testing new products in nail, skin and hair.
Valeant Pharmaceuticals International announced that its subsidiary, Valeant Pharmaceuticals North America, received approval from the Food and Drug Administration for its new drug application for Jublia (efinaconazole 10% topical solution). The drug is the first topical triazole approved for the treatment of onychomycosis of the toenails, the company said.